Clinical Trial Update: An Amniotic Membrane Injection Comparing Two Doses (1 mL and 2mL Injection) in the Treatment of Osteoarthritis of the Knee [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing two doses of an amniotic membrane injection for knee osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Snippet

Sponsor: Illinois Center for Orthopaedic Research and Education | Conditions: Osteoarthritis, Knee | Phase 4 | Status: WITHDRAWN